Regional chemotherapy in the treatment of advanced pancreatic cancer--is it relevant? (Q33961387)

30 July 2017

1 reference

title

Regional chemotherapy in the treatment of advanced pancreatic cancer--is it relevant? (English)

1 reference

30 July 2017

1 reference

Lorenz M

1

1 reference

30 July 2017

Heinrich S

2

1 reference

30 July 2017

Staib-Sebler E

3

1 reference

30 July 2017

Köhne CH

4

1 reference

30 July 2017

Wils J

5

1 reference

30 July 2017

Nordlinger B

6

1 reference

30 July 2017

Encke A

7

1 reference

30 July 2017

publication date

1 May 2000

1 reference

European Journal of Cancer

30 July 2017

published in

1 reference

30 July 2017

volume

36

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

957-965

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

30 July 2017

1 reference

7 January 2021

Current management of pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Management of pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Chemotherapy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

[The status of regional long-term chemotherapy in liver metastasis]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Pharmacokinetic studies of intraaortic stop-flow infusion with 14C-labeled mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Pharmacokinetics and tissue uptake of mitomycin C in isolated perfusion of pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Isolated perfusion of pancreas with mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Palliative and adjuvant regional chemotherapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900073-3

7 January 2021

10.1016/S0959-8049(00)00073-3

Identifiers

DOI

1 reference

release_ymmr7na3xzexdosq6cy4gzlboy

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ymmr7na3xzexdosq6cy4gzlboy

24 November 2022

mapped directly with Wikidata item

1 reference